Oakridge International Limited (OAK.AX)
AUD 0.05
(0.0%)
AUD 0.05
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -630.05 Thousand AUD | -209.37% |
| 2023 | -203.66 Thousand AUD | 22.97% |
| 2022 | -504.04 Thousand AUD | -11.78% |
| 2021 | -547.8 Thousand AUD | 58.25% |
| 2020 | -45.08 Thousand AUD | 51.11% |
| 2019 | -3.71 Million AUD | 33.39% |
| 2018 | -9.64 Million AUD | 33.47% |
| 2017 | -11.4 Million AUD | -306.65% |
| 2016 | -3.06 Million AUD | 200.39% |
| 2015 | -3.11 Million AUD | -292.57% |
| 2014 | -743.64 Thousand AUD | 79.38% |
| 2013 | -3.91 Million AUD | 87.26% |
| 2012 | -28.77 Million AUD | -1423.47% |
| 2011 | -1.85 Million AUD | 50.17% |
| 2010 | -3.74 Million AUD | -82.33% |
| 2009 | -1.61 Million AUD | -21.71% |
| 2008 | -988.79 Thousand AUD | -215.13% |
| 2007 | -455.35 Thousand AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | -140.42 Thousand AUD | 0.0% |
| 2024 Q2 | -521.71 Thousand AUD | 0.0% |
| 2024 FY | - AUD | -91.03% |
| 2023 Q4 | -164.57 Thousand AUD | 0.0% |
| 2023 Q2 | -307.14 Thousand AUD | 0.0% |
| 2023 FY | - AUD | 22.97% |
| 2022 Q2 | -370.6 Thousand AUD | 0.0% |
| 2022 Q4 | -256.12 Thousand AUD | 0.0% |
| 2022 FY | - AUD | -11.78% |
| 2021 Q4 | -275.35 Thousand AUD | 0.0% |
| 2021 FY | - AUD | 58.25% |
| 2021 Q2 | -344.54 Thousand AUD | 0.0% |
| 2020 FY | - AUD | 51.11% |
| 2020 Q2 | -1.02 Million AUD | 0.0% |
| 2020 Q4 | -351.19 Thousand AUD | 0.0% |
| 2019 FY | - AUD | 33.39% |
| 2019 Q4 | -1.3 Million AUD | 0.0% |
| 2019 Q2 | 234.78 Thousand AUD | 0.0% |
| 2018 Q2 | -1.68 Million AUD | 0.0% |
| 2018 FY | - AUD | 33.47% |
| 2018 Q4 | -2.34 Million AUD | 0.0% |
| 2017 FY | - AUD | -306.65% |
| 2017 Q2 | -3.67 Million AUD | 0.0% |
| 2017 Q4 | -2.38 Million AUD | 0.0% |
| 2016 Q3 | -1.16 Million AUD | -151.57% |
| 2016 FY | - AUD | 200.39% |
| 2016 Q4 | -2.33 Million AUD | -100.38% |
| 2016 Q1 | -232.04 Thousand AUD | 0.0% |
| 2016 Q2 | -464.09 Thousand AUD | -100.0% |
| 2015 FY | - AUD | -292.57% |
| 2014 FY | - AUD | 79.38% |
| 2013 FY | - AUD | 87.26% |
| 2012 FY | - AUD | -1423.47% |
| 2011 FY | - AUD | 50.17% |
| 2010 FY | - AUD | -82.33% |
| 2009 FY | - AUD | -21.71% |
| 2008 FY | - AUD | -215.13% |
| 2007 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alcidion Group Limited | -4.49 Million AUD | 85.986% |
| Artrya Limited | -13.95 Million AUD | 95.485% |
| Beamtree Holdings Limited | -331 Thousand AUD | -90.348% |
| Cogstate Limited | 9.89 Million AUD | 106.37% |
| Careteq Limited | -826.61 Thousand AUD | 23.779% |
| Doctor Care Anywhere Group PLC | -8.35 Million AUD | 92.458% |
| Emyria Limited | -13.03 Million AUD | 95.166% |
| Global Health Limited | -1.76 Million AUD | 64.319% |
| HITIQ Limited | -2.54 Million AUD | 75.22% |
| Intelicare Holdings Limited | -3.02 Million AUD | 79.141% |
| ImExHS Limited | -1.25 Million AUD | 49.905% |
| Mach7 Technologies Limited | -2.44 Million AUD | 74.2% |
| MedAdvisor Limited | 7.04 Million AUD | 108.939% |
| Opyl Limited | -3.2 Million AUD | 80.368% |
| PainChek Limited | -9.48 Million AUD | 93.36% |
| Pro Medicus Limited | 120.76 Million AUD | 100.522% |
| Resonance Health Limited | -457 Thousand AUD | -37.865% |
| Singular Health Group Ltd | -2.88 Million AUD | 78.162% |
| Total Brain Limited | -5.49 Million AUD | 88.526% |